Bracco Imaging has partnered with Italian company R.A.W. to expand its portfolio of solutions for interventional oncology.
One of the key challenges clinicians have to face during interventional procedures is the precise introduction of a probe into a deep target within the body that is not visible.
Clinical efforts in this field have been concentrated toward developing higher resolution images, better navigation and image fusion tools.
To address these clinical needs, R.A.W. developed Endosight™ a high-end guidance system based on augmented reality and a sophisticated imaging software (Ablation-fit™) for 3D reconstruction, planning and diagnosis to be used in surgery during mini-invasive Percutaneous Tumor Ablation procedures in Computed Tomography-based Interventional Oncology.
The solution has been developed to provide intuitive visualization with no need for manipulation or further interaction to ensure accurate targeting, without compromising workflow, procedure duration, or interventional outcomes.
Bracco Imaging CEO Fulvio Renoldi Bracco said: "We're delighted about this partnership as it will unleash new opportunities to address unmet medical needs in the field of Interventional Oncology.
"Endosight™ and Ablation-fit™ will further expand our portfolio of solutions with technologies that, I'm convinced, will significantly impact the clinician effectiveness during the procedure and the patient outcome."
Bracco Imaging chief strategy officer Micol Fornaroli said: "Bracco's journey focuses on the exploitation of new image-guided solutions for diagnosis and treatment of oncological diseases via internal developments and alliances.”
Ablation-fit™ will be initially distributed in Europe by Bracco Imaging through its commercial network.
Bracco Imaging, part of the Bracco Group, is one of the world's leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs.
Bracco Imaging offers a product and solution portfolio for all key diagnostic imaging modalities: X-ray Imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS), Nuclear Medicine through radioactive tracers.